Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer.

被引：0
|
作者：
Zemzoum, I
Schmitt, M
Ross, JS
Kiechle, M
Harbeck, N
机构：
[1] Tech Univ Munich, D-8000 Munich, Germany
[2] Albany Med Coll, Albany, NY 12208 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
127
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer
    Zemzoum, I
    Kates, RE
    Ross, JS
    Dettmar, P
    Dutta, M
    Henrichs, C
    Yurdseven, S
    Höfler, H
    Kiechle, M
    Schmitt, M
    Harbeck, N
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) : 1022 - 1028
  • [2] Prognostic significance of uPA/PAI-1 level, HER2 status, and traditional histologic factors for survival in node-negative breast cancer patients
    Dovnik, Nina Fokter
    Takac, Iztok
    RADIOLOGY AND ONCOLOGY, 2017, 51 (01) : 65 - 73
  • [3] UROKINASE (UPA) AND ITS INHIBITOR PAI-1 ARE STRONG AND INDEPENDENT PROGNOSTIC FACTORS IN NODE-NEGATIVE BREAST-CANCER
    JANICKE, F
    SCHMITT, M
    PACHE, L
    ULM, K
    HARBECK, N
    HOFLER, H
    GRAEFF, H
    BREAST CANCER RESEARCH AND TREATMENT, 1993, 24 (03) : 195 - 208
  • [4] Adjuvant Chemotherapy in Node-negative Breast Cancer: UPA/PAI-1 Determinations for 163 Cases
    Venat-Bouvet, Laurence
    Fermeaux, Veronique
    Leobon, Sophie
    Saidi, Nadira
    Monteil, Jacques
    Mollard, Joelle
    Aubard, Yves
    Jammet, Isabelle
    Tubiana-Mathieu, Nicole
    ANTICANCER RESEARCH, 2014, 34 (03) : 1213 - 1217
  • [5] Tumorbiological factors (uPA, PAI-1) as selection criteria for adjuvant chemotherapy in axillary node-negative breast cancer patients
    Jänicke, F
    Thomssen, C
    Harbeck, N
    Prechtl, A
    Berger, U
    Ulm, K
    Dettmar, P
    Pache, L
    Schmitt, M
    Graeff, H
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S24 - S25
  • [6] uPA/PAI-1 as a predictive Factor in HR+ and HER2 Breast Cancer
    Wieder, V
    Kaufhold, S.
    Kantelhardt, J. E.
    Thomssen, C.
    Vetter, M.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (06) : E25 - E25
  • [7] PAI-1 polymorphism and expression of uPA, PAI-1 and COX-2 in breast cancer.
    Minisini, AM
    Di Loreto, C
    Pestrin, M
    Fabbro, D
    Cardellino, GG
    Russo, S
    Andreetta, C
    Damante, G
    Piga, A
    Puglisi, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 879S - 879S
  • [8] ADJUVANT CHEMOTHERAPY IN NODE-NEGATIVE (N0) BREAST CANCER: ROUTINE UPA/PAI-1 DETERMINATION
    Tubiana-Mathieu, N.
    Fermeaux, V.
    Saidi, N.
    Monteil, J.
    Mollard, J.
    Aubard, Y.
    Jammet, I.
    Venat-Bouvet, L.
    ANNALS OF ONCOLOGY, 2012, 23 : 24 - 24
  • [9] Tumor-biological factors uPA and PAI-1 as stratification criteria of a multicenter adjuvant chemotherapy trial in node-negative breast cancer
    Prechtl, A
    Harbeck, N
    Thomssen, C
    Meisner, C
    Braun, M
    Untch, M
    Wieland, M
    Lisboa, B
    Cufer, T
    Graeff, H
    Selbmann, K
    Schmitt, M
    Jänicke, F
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (01): : 73 - 78
  • [10] Invasion factors uPA and PAI-1 in node-negative breast cancer: Transfer of laboratory data into clinical practice as exemplified by the ongoing NNBC 3-Europe trial
    Vetter, M.
    Kantelhardt, E. J.
    Annecke, K.
    Dittmer, J.
    Paepke, D.
    Precht, A.
    Schmitt, M.
    Jaenicke, F.
    Minckwitz, G. V.
    Kiechle-Bahat, M.
    Thomssen, C.
    Harbeck, N.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (10) : 1144 - 1152
12345